Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2007 by National Cancer Institute (NCI).
Recruitment status was Not yet recruiting

Sponsor:

Collaborator:

Information provided by:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00369954

First received: August 29, 2006

Last updated: April 14, 2009

Last verified: October 2007

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2007 (Final data collection date for primary outcome measure)